These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25931042)

  • 1. Radioiodine therapy for Graves' disease - retrospective analysis of efficacy factors.
    Szumowski P; Abdelrazek S; Kociura Sawicka A; Mojsak M; Kostecki J; Sykała M; Myśliwiec J
    Endokrynol Pol; 2015; 66(2):126-31. PubMed ID: 25931042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Nowak B; Ostwald E; Schäfer W; Block S; Setani K; Büll U
    Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.
    Reinhardt MJ; Brink I; Joe AY; Von Mallek D; Ezziddin S; Palmedo H; Krause TM
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1118-24. PubMed ID: 12192554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidism.
    Grosso M; Traino A; Boni G; Banti E; Della Porta M; Manca G; Volterrani D; Chiacchio S; AlSharif A; Borsò E; Raschillà R; Di Martino F; Mariani G
    Cancer Biother Radiopharm; 2005 Apr; 20(2):218-23. PubMed ID: 15869459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience with ambulatory radioiodine therapy of hyperthyroidism].
    Róka R; Séra T; Valkusz Z; Julesz J; Csernay L; Pávics L
    Orv Hetil; 1999 Jun; 140(23):1291-5. PubMed ID: 10412264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
    Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between thyroid volume and humoral thyroid autoimmunity after radioiodine therapy in Graves' disease.
    Sawicka N; Sowiński J
    Endokrynol Pol; 2012; 63(1):10-3. PubMed ID: 22378091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine therapy in Graves' hyperthyroidism: determination of individual optimum target dose.
    Haase A; Bähre M; Lauer I; Meller B; Richter E
    Exp Clin Endocrinol Diabetes; 2000; 108(2):133-7. PubMed ID: 10826521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study.
    Peters H; Fischer C; Bogner U; Reiners C; Schleusener H
    Eur J Clin Invest; 1996 Jan; 26(1):59-63. PubMed ID: 8682157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
    Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome.
    Catargi B; Leprat F; Guyot M; Valli N; Ducassou D; Tabarin A
    Eur J Endocrinol; 1999 Aug; 141(2):117-21. PubMed ID: 10427153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid echogenicity predicts outcome of radioiodine therapy in patients with Graves' disease.
    Markovic V; Eterovic D
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3547-52. PubMed ID: 17609305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
    Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
    Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximum dose rate is a determinant of hypothyroidism after 131I therapy of Graves' disease but the total thyroid absorbed dose is not.
    Krohn T; Hänscheid H; Müller B; Behrendt FF; Heinzel A; Mottaghy FM; Verburg FA
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4109-15. PubMed ID: 25033065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
    Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
    Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outcome of 131I treatment in Graves' patients pretreated or not with methimazole.
    Pirnat E; Zaletel K; Gaberšček S; Hojker S
    Hell J Nucl Med; 2011; 14(1):25-9. PubMed ID: 21512661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease].
    Guhlmann CA; Rendl J; Börner W
    Nuklearmedizin; 1995 Feb; 34(1):20-3. PubMed ID: 7724360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism.
    Traino AC; Di Martino F; Lazzeri M; Stabin MG
    Phys Med Biol; 2000 Jan; 45(1):121-9. PubMed ID: 10661587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possibility of limiting the un-justified irradiation in (131)I therapy of Graves' disease: a thyroid mass-reduction based method for the optimum activity calculation.
    Traino AC; Grosso M; Mariani G
    Phys Med; 2010 Apr; 26(2):71-9. PubMed ID: 19800827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.